I

Instituto Cardiovascular San Luis | Clinical Research Department

Research site
(Unclaimed)
Location
Rivadavia 1059, San Luis, San Luis, Argentina
Site insights

Top conditions

Myocardial Infarction (1 trial)

Coronary Disease (1 trial)

Heart Diseases (1 trial)

Atrial Flutter (1 trial)

Heart Failure (1 trial)

Top treatments

Evolocumab
Tirzepatide
LY3298176

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejec...

Active, not recruiting
Heart Failure With Preserved Ejection Fraction (HFpEF)
Obesity
Other: Placebo
Drug: Tirzepatide

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

Trial sponsors

Amgen logo

Amgen (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems